Natera Says Its Signatera Test Gets Japan Approval as Bladder Cancer Companion Diagnostic
MT newswire2026/09/22 12:41Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
08:41 AM EDT, 09/22/2026 (MT Newswires) -- Natera (NTRA) said Tuesday that Japan's Pharmaceuticals and Medical Devices Agency has approved the company's Signatera test as a companion diagnostic for muscle-invasive bladder cancer. The approval supports using Signatera to guide adjuvant atezolizumab treatment decisions in patients with muscle-invasive bladder cancer, the company said. Natera said it expects to commercially launch the test in Japan in H1 of next year, following approval of atezolizumab for the indication. The approval was supported by data from the late-stage IMvigor011 trial, the company said.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Société Générale exits Hugo Boss stake, voting rights fall to 0% from 6.09%
Bitget•2026/09/22 13:55
AQR Capital Management discloses net short position in Eurofins Scientific
Bitget•2026/09/22 13:55
Mirabella Financial Services discloses net short position in VusionGroup
Bitget•2026/09/22 13:54
Hyliion to Dual List Shares on NYSE Texas
MT newswire•2026/09/22 13:54
Crypto prices
MoreBitcoin
BTC
$86,098.49
+0.85%
Ethereum
ETH
$2,753.12
+0.77%
Tether USDt
USDT
$0.9998
+0.02%
BNB
BNB
$788.01
+0.19%
XRP
XRP
$1.57
+5.01%
USDC
USDC
$1.0000
+0.02%
Solana
SOL
$117.55
-0.31%
TRON
TRX
$0.3429
-0.53%
Zcash
ZEC
$1,515.99
-1.57%
Hyperliquid
HYPE
$95.4
+0.49%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now